Fresenius Medical Care AG & Co. KGaA (ADR)

General ticker "FMS" information:

  • Sector: Health Care
  • Industry: Medical - Care Facilities
  • Capitalization: $14.7B (TTM average)

Fresenius Medical Care AG & Co. KGaA (ADR) does not follow the US Stock Market performance with the rate: -27.4%.

Estimated limits based on current volatility of 0.9%: low 20.69$, high 21.08$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-05-22, amount 0.87$ (Y4.16%)
  • Total employees count: 47521 as of 2005
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [20.80$, 29.83$]
  • 2026-12-31 to 2027-12-31 estimated range: [22.73$, 32.25$]

Financial Metrics affecting the FMS estimates:

  • Positive: with PPE of 9.8 at the end of fiscal year the price was neutral
  • Positive: Operating cash flow per share per price, % of 21.81 > 12.90
  • Positive: 7.54 < Operating profit margin, % of 9.31
  • Negative: Return on assets ratio (scaled to [-100,100]) of 3.06 <= 6.06
  • Negative: Industry operating profit margin (median), % of 0.04 <= 2.88
  • Negative: -0.16 < Industry inventory ratio change (median), % of 0
  • Negative: 0 < Inventory ratio change, % of 0.52
  • Negative: 0.73 < Interest expense per share per price, % of 3.26
  • Negative: Industry operating cash flow per share per price (median), % of 5.14 <= 5.46

Similar symbols

Short-term FMS quotes

Long-term FMS plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €19,453.62MM €19,335.91MM €19,627.60MM
Operating Expenses €18,084.18MM €17,868.53MM €17,800.78MM
Operating Income €1,369.44MM €1,467.38MM €1,826.82MM
Non-Operating Income €-336.42MM €-410.45MM €-314.59MM
Interest Expense €424.64MM €407.04MM €384.41MM
R&D Expense €231.97MM €183.49MM €157.97MM
Income(Loss) €1,033.02MM €1,056.93MM €1,512.24MM
Taxes €300.56MM €316.06MM €320.97MM
Net Income(Loss)* €499.00MM €537.91MM €978.37MM
Stockholders Equity €13,620.26MM €14,576.56MM €14,283.00MM
Inventory €2,179.18MM €2,067.92MM €2,141.00MM
Assets €33,929.81MM €33,566.58MM €31,002.00MM
Operating Cash Flow €2,628.80MM €2,386.14MM €2,575.19MM
Capital expenditure €684.60MM €699.36MM €879.24MM
Investing Cash Flow €-544.23MM €-84.94MM €-666.18MM
Financing Cash Flow €-1,858.53MM €-2,569.30MM €-1,375.66MM
Earnings Per Share** €0.85 €0.91 €1.68
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.